Our Work


LDAA Analysis of Dr Michelle Wills' thesis

In November 2017, the LDAA ensured the 1995 thesis of Dr Michelle Wills became publicly available. In December 2017, the LDAA has analysed the thesis, to present you with the key information.

Targeted Call for Research

The Lyme Disease Association of Australia represented patients in this call for research priorities.
You can view the submission in full here.

 LDAA Senate Inquiry Submission

The Lyme Disease Association of Australia represented patients at this important inquiry into Lyme-like illness in Australia.
You can view the submission in full here.

 LDAA Senate Inquiry Supplementary Submission

The Lyme Disease Association of Australia's supplementary submission (#528ss2) to the Senate Inquiry into Lyme-like illness in Australia.

You can view the submission in full here.

Counter-arguments and Responses

The LDAA prepares and develops appropriate counter-arguments in response to other organizations position or policy statements which impact the Lyme Disease patient and related community members.

Clinical Advisory Committee on Lyme Disease

The LDAA performs a number of important functions relating to the Clinical Advisory Committee on Lyme Disease (CACLD) established and currently run by the Australian Government. The first is having secured a place for a patient representative on the committee to ensure patient requirements are sufficiently and adequately represented.  The second is to respond to requests for public submissions from the CACLD by way of development and production of appropriate researched and informed responses.

Patient surveys and statistical collection

As many would be aware Lyme Disease in Australia is not currently notifiable so it is important the LDAA collects and collates necessary data to inform on-going strategy and development of necessary submissions and counter-arguments. If you are more visual head to our statistics section to see the reality of Lyme disease in Australia.

Back to top